Former Secretary of Veterans Affairs James Peake to Join the Cellphire Board of Directors

Former Secretary of Veterans Affairs James Peake to Join the Cellphire Board
of Directors

Peake to provide guidance and direction regarding military needs, clinical
uses and funding sources

ROCKVILLE, Md., June 30 /PRNewswire/ -- Cellphire, Inc., a biotechnology
company located in Rockville, Md., announced today that former Secretary of
the Department of Veterans Affairs, James Peake, MD, has joined its board of
directors.

"I am excited about the potential of Thrombosomes(R) to save lives on the
battlefield and in emergency rooms throughout the US. I am eager to contribute
to the effort to conduct appropriate clinical trials to evaluate and
ultimately field this product," said Dr. Peake.

Cellphire is committed to developing a freeze-dried platelet product,
Thrombosomes(R), which could potentially be effective in stopping
uncontrollable bleeding on the battlefield or in trauma. Platelets can only be
stored for 5 days and cannot be provided to combat zones, although
in-the-field harvesting is being performed. Cellphire's product is expected to
have a 12 month shelf life and be immediately available for infusion after
adding sterile water.

"We are excited about the addition of Dr. Peake to the Cellphire Board," said
Cellphire President Mike Fitzpatrick. "With his incomparable experience and
tireless commitment to providing the best possible care for the active duty
uniformed services and veterans, we feel sure his contributions will help us
achieve our goal."

Dr. Peake is a retired U.S. Army Lieutenant General; he was selected as the
U.S. Army Surgeon General. After retirement from the Army he served as the
Executive Vice President and Chief Operating Officer of Project Hope and most
recently as the Secretary of the U.S. Department of Veterans Affairs. A native
of St. Louis and graduate of the U.S. Military Academy at West Point, Peake
attended medical school after serving in Vietnam with the 101st Airborne
Division, where he was awarded the Silver Star and Purple Heart.

About Cellphire
Cellphire, Inc., a biotechnology company, is focused on developing stabilized
cellular materials for advanced technologies in the therapeutic and diagnostic
markets. Current efforts and product development are aimed toward stabilized
platelets for advanced wound care, transfusion, and reagent products for
clinical and research diagnostics.

For more information please visit: http://www.cellphire.com/.

SOURCE Cellphire, Inc.

Richard Cliff of Cellphire, +1-240-268-1141, ext. 208, rcliff@cellphire.com